Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee

NCT03062787 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DEVICE: Cingal® (Hyaluronic Acid plus Triamcinolone Hexacetonide)
DEVICE: Monovisc® (Sodium hyaluronate)

Sponsor

Pharmascience Inc.